345 related articles for article (PubMed ID: 25218215)
1. Transgenerational inheritance of prenatal obesogen exposure.
Janesick AS; Shioda T; Blumberg B
Mol Cell Endocrinol; 2014 Dec; 398(1-2):31-5. PubMed ID: 25218215
[TBL] [Abstract][Full Text] [Related]
2. Transgenerational effects of obesogens.
Lee MK; Blumberg B
Basic Clin Pharmacol Toxicol; 2019 Aug; 125 Suppl 3(Suppl 3):44-57. PubMed ID: 30801972
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic Transgenerational Inheritance of the Effects of Obesogen Exposure.
Mohajer N; Joloya EM; Seo J; Shioda T; Blumberg B
Front Endocrinol (Lausanne); 2021; 12():787580. PubMed ID: 34975759
[TBL] [Abstract][Full Text] [Related]
4. Obesogens, stem cells and the developmental programming of obesity.
Janesick A; Blumberg B
Int J Androl; 2012 Jun; 35(3):437-48. PubMed ID: 22372658
[TBL] [Abstract][Full Text] [Related]
5. Endocrine disruptors and obesity.
Heindel JJ; Newbold R; Schug TT
Nat Rev Endocrinol; 2015 Nov; 11(11):653-61. PubMed ID: 26391979
[TBL] [Abstract][Full Text] [Related]
6. Environmental Obesogens and Their Impact on Susceptibility to Obesity: New Mechanisms and Chemicals.
Egusquiza RJ; Blumberg B
Endocrinology; 2020 Mar; 161(3):. PubMed ID: 32067051
[TBL] [Abstract][Full Text] [Related]
7. Environmental endocrine disruptors and obesity.
Karoutsou E; Polymeris A
Endocr Regul; 2012 Jan; 46(1):37-46. PubMed ID: 22329821
[TBL] [Abstract][Full Text] [Related]
8. Obesogens: an emerging threat to public health.
Janesick AS; Blumberg B
Am J Obstet Gynecol; 2016 May; 214(5):559-65. PubMed ID: 26829510
[TBL] [Abstract][Full Text] [Related]
9. The Role of Epigenetics in the Latent Effects of Early Life Exposure to Obesogenic Endocrine Disrupting Chemicals.
Stel J; Legler J
Endocrinology; 2015 Oct; 156(10):3466-72. PubMed ID: 26241072
[TBL] [Abstract][Full Text] [Related]
10. Obesogens, stem cells and the maternal programming of obesity.
Blumberg B
J Dev Orig Health Dis; 2011 Feb; 2(1):3-8. PubMed ID: 26401242
[TBL] [Abstract][Full Text] [Related]
11. Environmental obesogens: organotins and endocrine disruption via nuclear receptor signaling.
Grün F; Blumberg B
Endocrinology; 2006 Jun; 147(6 Suppl):S50-5. PubMed ID: 16690801
[TBL] [Abstract][Full Text] [Related]
12. Endocrine Disruptors and Obesity.
Darbre PD
Curr Obes Rep; 2017 Mar; 6(1):18-27. PubMed ID: 28205155
[TBL] [Abstract][Full Text] [Related]
13. Endocrine disrupting chemicals and the developmental programming of adipogenesis and obesity.
Janesick A; Blumberg B
Birth Defects Res C Embryo Today; 2011 Mar; 93(1):34-50. PubMed ID: 21425440
[TBL] [Abstract][Full Text] [Related]
14. Inherited Epigenetic Hallmarks of Childhood Obesity Derived from Prenatal Exposure to Obesogens.
Núñez-Sánchez MÁ; Jiménez-Méndez A; Suárez-Cortés M; Martínez-Sánchez MA; Sánchez-Solís M; Blanco-Carnero JE; Ruiz-Alcaraz AJ; Ramos-Molina B
Int J Environ Res Public Health; 2023 Mar; 20(6):. PubMed ID: 36981620
[TBL] [Abstract][Full Text] [Related]
15. Obesity II: Establishing causal links between chemical exposures and obesity.
Heindel JJ; Howard S; Agay-Shay K; Arrebola JP; Audouze K; Babin PJ; Barouki R; Bansal A; Blanc E; Cave MC; Chatterjee S; Chevalier N; Choudhury M; Collier D; Connolly L; Coumoul X; Garruti G; Gilbertson M; Hoepner LA; Holloway AC; Howell G; Kassotis CD; Kay MK; Kim MJ; Lagadic-Gossmann D; Langouet S; Legrand A; Li Z; Le Mentec H; Lind L; Monica Lind P; Lustig RH; Martin-Chouly C; Munic Kos V; Podechard N; Roepke TA; Sargis RM; Starling A; Tomlinson CR; Touma C; Vondracek J; Vom Saal F; Blumberg B
Biochem Pharmacol; 2022 May; 199():115015. PubMed ID: 35395240
[TBL] [Abstract][Full Text] [Related]
16. Environmental Obesogens: Mechanisms and Controversies.
Heindel JJ; Blumberg B
Annu Rev Pharmacol Toxicol; 2019 Jan; 59():89-106. PubMed ID: 30044726
[TBL] [Abstract][Full Text] [Related]
17. Obesogens: How They Are Identified and Molecular Mechanisms Underlying Their Action.
Mohajer N; Du CY; Checkcinco C; Blumberg B
Front Endocrinol (Lausanne); 2021; 12():780888. PubMed ID: 34899613
[TBL] [Abstract][Full Text] [Related]
18. Obesity and endocrine-disrupting chemicals.
Amato AA; Wheeler HB; Blumberg B
Endocr Connect; 2021 Feb; 10(2):R87-R105. PubMed ID: 33449914
[TBL] [Abstract][Full Text] [Related]
19. [Synthetic phenolic compounds perturb lipid metabolism and induce obesogenic effects].
Liu HN; Sun ZD; Liu Q; Zhou QF; Jiang GB
Se Pu; 2024 Feb; 42(2):131-141. PubMed ID: 38374593
[TBL] [Abstract][Full Text] [Related]
20. Minireview: PPARγ as the target of obesogens.
Janesick A; Blumberg B
J Steroid Biochem Mol Biol; 2011 Oct; 127(1-2):4-8. PubMed ID: 21251979
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
